|
KBTBD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.69390004432091E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03609999971377E-07 |
| Normal-vs-Stage2 |
2.059100E-03 |
| Normal-vs-Stage3 |
5.48740000105852E-08 |
| Normal-vs-Stage4 |
5.03029999876503E-08 |
| Stage1-vs-Stage2 |
4.436600E-01 |
| Stage1-vs-Stage3 |
2.200400E-01 |
| Stage1-vs-Stage4 |
5.993900E-02 |
| Stage2-vs-Stage3 |
1.320840E-01 |
| Stage2-vs-Stage4 |
5.951900E-02 |
| Stage3-vs-Stage4 |
5.395800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.16660000840596E-09 |
| Normal-vs-AfricanAmerican |
2.107600E-02 |
| Normal-vs-Asian |
4.619900E-04 |
| Caucasian-vs-AfricanAmerican |
2.258200E-01 |
| Caucasian-vs-Asian |
4.687200E-01 |
| AfricanAmerican-vs-Asian |
5.907600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.8829999498825E-09 |
| Normal-vs-Female |
1.74159999977164E-07 |
| Male-vs-Female |
5.327900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.394400000021E-06 |
| Normal-vs-Age(41-60Yrs) |
7.959600000218E-07 |
| Normal-vs-Age(61-80Yrs) |
1.16949999684479E-08 |
| Normal-vs-Age(81-100Yrs) |
5.061000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.470600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.236000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.220000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.872850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.991800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.755600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.369040E-01 |
| Classical-VS-Follicular |
4.455600E-02 |
| Classical-VS-Other |
1.891840E-01 |
| Classical-VS-Normal |
8.35489999961858E-07 |
| Tall-VS-Follicular |
8.830800E-01 |
| Tall-VS-Other |
5.585400E-01 |
| Tall-VS-Normal |
2.35930000003215E-06 |
| Follicular-VS-Other |
5.756800E-01 |
| Follicular-VS-Normal |
3.86560000009695E-07 |
| Other-VS-Normal |
5.263000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.9712999978554E-08 |
| Normal-vs-N1 |
1.55029999948653E-08 |
| N0-vs-N1 |
4.007700E-02 |
|
|
